➡ Since initial reports of inhaler technique difficulties in 1965 over 14,000 publication have explored the subject but the problems continue to exist.
➡ Inhaler technique training is called for in GINA, GOLD and other reports and a plethora of tools exist to conduct inhaler training, and yet the problem persists…
➡ This presentation reviews what has been done and the potential for new technologies in future.
➡ How to make the most of post-market data to develop safe and effective medical devices
➡ An overview of the Global Inhalation Market, Leading Brands Indication and Sales for both Asthma and COPD and non-Asthma and COPD indications, Current Market and Indication Trends including Generics and Products in Late Stage Development
➡ Respiratory and Non-Respiratory Indications, Disease States with Increasing Global Burden, Prioritization of Therapeutic Strategies (Relevant Examples); Lung Architecture and the Lungs as a portal for Systemic Delivery; Overview of Pulmonary Drug Delivery Technology (Nebulizers, pMDIs, DPIs)
➡ The Case for Respirable Engineered Spray Dried Dry Powder, Pulmonary Particle Deposition using Gamma Scintigraphy and Systemic PK, Local Lung Delivery (Tobi Podhaler), Platform Approach and the 505(b)(2) Regulatory Pathway
➡ Analytical insights into dry powder formulations for inhalation.
➡ Characterizing aerosol dynamics
➡ Tests according to ISO 18562-2,-3,-4
20-21 June 2023 @World of Wine Porto, Portugal